Kiniksa Pharmaceuticals, Ltd.

Direct answer

Kiniksa Pharmaceuticals, Ltd. is publicly traded on NASDAQ under the ticker KNSA.

Kiniksa Pharmaceuticals, Ltd. is a global biopharmaceutical firm dedicated to discovering, acquiring, advancing, and commercializing medical therapies for individuals suffering from severe illnesses where current treatment options are insufficient. Its pipeline of potential treatments includes ARCALYST, an interleukin-1alpha and interleukin-1beta inhibitor, aimed at addressing recurrent pericarditis, an inflammatory...

Can you invest in Kiniksa Pharmaceuticals, Ltd.?

Yes. Kiniksa Pharmaceuticals, Ltd. trades publicly on NASDAQ as KNSA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Kiniksa Pharmaceuticals, Ltd.

Detailed equity research is provided by MarketSnap.